Smart Sensors and Microtechnologies in the Precision Medicine Approach against Lung Cancer
暂无分享,去创建一个
[1] Sungjune Jung,et al. 3D Inkjet-Bioprinted Lung-on-a-Chip. , 2023, ACS biomaterials science & engineering.
[2] Ramanathan Karuppasamy,et al. Sequential virtual screening collaborated with machine-learning strategies for the discovery of precise medicine against non-small cell lung cancer. , 2023, Journal of biomolecular structure & dynamics.
[3] H. Haick,et al. Artificial Intelligence‐Based Medical Sensors for Healthcare System , 2023, Advanced Sensor Research.
[4] G. Giannelli,et al. Organs-on-chips technologies - A guide from disease models to opportunities for drug development. , 2023, Biosensors & bioelectronics.
[5] Michael N. Kammer,et al. It Doesn't Smell Like Cancer to Me: The Promise of Exhaled Breath Biomarkers for Lung Cancer Diagnosis. , 2023, Chest.
[6] C. Barner‐Kowollik,et al. Laser printed microelectronics , 2023, Nature Communications.
[7] Yajun Lin,et al. Recent progress in targeted therapy for non-small cell lung cancer , 2023, Frontiers in Pharmacology.
[8] Anubhab Mukherjee,et al. Lung cancer immunotherapy: progress, pitfalls, and promises , 2023, Molecular Cancer.
[9] C. Bortolotto,et al. Smoking Habit and Respiratory Function Predict Patients’ Outcome after Surgery for Lung Cancer, Irrespective of Histotype and Disease Stage , 2023, Journal of clinical medicine.
[10] Huikai Xie,et al. Review of Piezoelectric Micromachined Ultrasonic Transducers for Rangefinders , 2023, Micromachines.
[11] T. Mok,et al. Non-oncogene addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up†. , 2023, Annals of oncology : official journal of the European Society for Medical Oncology.
[12] A. Jemal,et al. Cancer statistics, 2023 , 2023, CA: a cancer journal for clinicians.
[13] Xiaoning Jiang,et al. Piezoelectric Micromachined Ultrasound Transducer Technology: Recent Advances and Applications , 2022, Biosensors.
[14] Haleh Nazemi,et al. Piezoelectric Micromachined Ultrasonic Transducers (PMUTs): Performance Metrics, Advancements, and Applications , 2022, Sensors.
[15] J. Sharifi‐Rad,et al. Biosensing chips for cancer diagnosis and treatment: a new wave towards clinical innovation , 2022, Cancer Cell International.
[16] H. Sung,et al. Semiconductor Work, Leukemia, and Cancer Risk: A Systematic Review and Meta-Analysis , 2022, International journal of environmental research and public health.
[17] Mojgan Sheikhpour,et al. An in silico comparative transcriptome analysis identifying hub lncRNAs and mRNAs in brain metastatic small cell lung cancer (SCLC) , 2022, Scientific Reports.
[18] E. Yeini,et al. 3D bioprinted cancer models: from basic biology to drug development , 2022, Nature Reviews Cancer.
[19] B. E. van den Borne,et al. Diagnosing non-small cell lung cancer by exhaled-breath profiling using an electronic nose: a multicentre validation study. , 2022, Chest.
[20] W. Voigt,et al. Clinical Scores, Biomarkers and IT Tools in Lung Cancer Screening—Can an Integrated Approach Overcome Current Challenges? , 2022, Cancers.
[21] N. Dalay,et al. The let-7 microRNA binding site variant in KRAS as a predictive biomarker for head and neck cancer patients with lymph node metastasis. , 2022, Pathology, research and practice.
[22] Wei Li,et al. Recent Advances in the Application of Piezoelectric Materials in Microrobotic Systems , 2022, Micromachines.
[23] A. Kamaya,et al. Improving plane wave ultrasound imaging through real-time beamformation across multiple arrays , 2022, Scientific Reports.
[24] Yangqiu Li,et al. Current insight into the regulation of PD-L1 in cancer , 2022, Experimental Hematology & Oncology.
[25] S. Petralia,et al. A Miniaturized Silicon Lab-on-Chip for Integrated PCR and Hybridization Microarray for High Multiplexing Nucleic Acids Analysis , 2022, Biosensors.
[26] Qi Zhang,et al. Nanotech Probes: A Revolution in Cancer Diagnosis , 2022, Frontiers in Oncology.
[27] Y. Mei,et al. Recent advances in microsystem approaches for mechanical characterization of soft biological tissues , 2022, Microsystems & nanoengineering.
[28] Z. Vajglová,et al. Microreactor technology in experimental and modelling study of alcohol oxidation on nanogold , 2022, Chemical Engineering Science.
[29] M. Rehman,et al. MiRNAs in Lung Cancer: Diagnostic, Prognostic, and Therapeutic Potential , 2022, Diagnostics.
[30] W. Lasek. Cancer immunoediting hypothesis: history, clinical implications and controversies , 2022, Central-European journal of immunology.
[31] A. Del Conte,et al. Targeted Therapy and Immunotherapy in Early-Stage Non-Small Cell Lung Cancer: Current Evidence and Ongoing Trials , 2022, International journal of molecular sciences.
[32] J. Minden,et al. Microfluidics for understanding model organisms , 2022, Nature Communications.
[33] D. Beebe,et al. A role for microfluidic systems in precision medicine , 2022, Nature Communications.
[34] H. Asadzadeh Aghdaei,et al. Patient-derived xenograft (PDX) models, applications and challenges in cancer research , 2022, Journal of translational medicine.
[35] R. Levine,et al. Targeting mutations in cancer , 2022, The Journal of clinical investigation.
[36] A. Srivastava,et al. Next-Generation Intelligent MXene-Based Electrochemical Aptasensors for Point-of-Care Cancer Diagnostics , 2022, Nano-Micro Letters.
[37] H. Klauk,et al. Nanoscale flexible organic thin-film transistors , 2022, Science advances.
[38] Yue Wang,et al. CAR‐T cell therapy for lung cancer: Potential and perspective , 2022, Thoracic cancer.
[39] H. Romanowicz,et al. miRNAs in Cancer (Review of Literature) , 2022, International journal of molecular sciences.
[40] A. Adjei,et al. Challenges in the Use of Targeted Therapies in Non–Small Cell Lung Cancer , 2022, Cancer research and treatment.
[41] A. Grumezescu,et al. Microelectromechanical Systems (MEMS) for Biomedical Applications , 2022, Micromachines.
[42] C. Gridelli,et al. Chemotherapy plus single/double immunotherapy in the treatment of non-oncogene addicted advanced non-small cell lung cancer: where do we stand and where are we going? , 2022, Expert review of anticancer therapy.
[43] Baosheng Li,et al. Adverse events of immunotherapy in non-small cell lung cancer: A systematic review and network meta-analysis. , 2021, International immunopharmacology.
[44] Rajendran J C Bose,et al. Ultrasound-Guided Microbubble-Mediated Locoregional Delivery of Multiple MicroRNAs Improves Chemotherapy in Hepatocellular Carcinoma , 2022, Nanotheranostics.
[45] T. Rungrotmongkol,et al. In Silico Screening of Available Drugs Targeting Non-Small Cell Lung Cancer Targets: A Drug Repurposing Approach , 2021, Pharmaceutics.
[46] Yuanxin Chen,et al. Research Progress, Challenges, and Breakthroughs of Organoids as Disease Models , 2021, Frontiers in Cell and Developmental Biology.
[47] Jingtao Zhang,et al. Chimeric Antigen Receptor T-Cell Therapy in Lung Cancer: Potential and Challenges , 2021, Frontiers in Immunology.
[48] R. Tade,et al. Graphene quantum dots (GQDs) nanoarchitectonics for theranostic application in lung cancer , 2021, Journal of drug targeting.
[49] Shangke Huang,et al. Efficacy and safety of PD-1/PD-L1 plus CTLA-4 antibodies ± other therapies in lung cancer: a systematic review and meta-analysis , 2021, European journal of hospital pharmacy : science and practice.
[50] B. Dubashi,et al. Challenges in the Management of Lung Cancer: Real-World Experience from a Tertiary Center in South India , 2021, South Asian Journal of Cancer.
[51] M. D. Peris-Díaz,et al. Current Landscape of Non-Small Cell Lung Cancer: Epidemiology, Histological Classification, Targeted Therapies, and Immunotherapy , 2021, Cancers.
[52] O. Bălăcescu,et al. Next Generation Sequencing Technology in Lung Cancer Diagnosis , 2021, Biology.
[53] P. Comoli,et al. Local Therapies and Modulation of Tumor Surrounding Stroma in Malignant Pleural Mesothelioma: A Translational Approach , 2021, International journal of molecular sciences.
[54] C. Boshoff,et al. Toward personalized treatment approaches for non-small-cell lung cancer , 2021, Nature Medicine.
[55] Youngmee Jung,et al. Three-Dimensional Vascularized Lung Cancer-on-a-Chip with Lung Extracellular Matrix Hydrogels for In Vitro Screening , 2021, Cancers.
[56] J. R. Petrus,et al. Ultrasound-on-chip platform for medical imaging, analysis, and collective intelligence , 2021, Proceedings of the National Academy of Sciences.
[57] Ning Hu,et al. Tumor-on-a-chip: from bioinspired design to biomedical application , 2021, Microsystems & nanoengineering.
[58] Q. Cheng,et al. Regulatory mechanisms of immune checkpoints PD-L1 and CTLA-4 in cancer , 2021, Journal of experimental & clinical cancer research : CR.
[59] R. Henrique,et al. Emerging Lab-on-a-Chip Approaches for Liquid Biopsy in Lung Cancer: Status in CTCs and ctDNA Research and Clinical Validation , 2021, Cancers.
[60] E. Fröhlich,et al. Oral inhalation for delivery of proteins and peptides to the lungs. , 2021, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[61] M. Spitzer,et al. Systemic immunity in cancer , 2021, Nature Reviews Cancer.
[62] M. Norton,et al. Point-of-care cancer diagnostic devices: From academic research to clinical translation. , 2021, Talanta.
[63] T. Noor,et al. Cancer models in preclinical research: A chronicle review of advancement in effective cancer research , 2021, Animal models and experimental medicine.
[64] Joo-Yeon Yoo,et al. All‐Inkjet‐Printed 3D Alveolar Barrier Model with Physiologically Relevant Microarchitecture , 2021, Advanced science.
[65] U. Malapelle,et al. Novel Emerging Molecular Targets in Non-Small Cell Lung Cancer , 2021, International journal of molecular sciences.
[66] Danling Wang,et al. 2D Nanomaterial, Ti3C2 MXene-Based Sensor to Guide Lung Cancer Therapy and Management † , 2021, Biosensors.
[67] D. Carbone,et al. First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in patients with non-small-cell lung cancer (CheckMate 9LA): an international, randomised, open-label, phase 3 trial. , 2021, The Lancet. Oncology.
[68] P. Massion,et al. Biomarkers in Lung Cancer Screening: a Narrative Review. , 2021, Current challenges in thoracic surgery.
[69] Sahar Sadat Mahshid,et al. The potential application of electrochemical biosensors in the COVID-19 pandemic: A perspective on the rapid diagnostics of SARS-CoV-2 , 2020, Biosensors and Bioelectronics.
[70] Zida Li,et al. Emerging biosensing technologies for improved diagnostics of COVID-19 and future pandemics , 2020, Talanta.
[71] J. Borlak,et al. miRNAs in lung cancer. A systematic review identifies predictive and prognostic miRNA candidates for precision medicine in lung cancer. , 2020, Translational research : the journal of laboratory and clinical medicine.
[72] Yi-long Wu,et al. Brief report: Four-year survival with durvalumab after chemoradiotherapy in Stage III NSCLC - an update from the PACIFIC trial. , 2020, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[73] S. Y. Kim,et al. Update 2020: Management of Non-Small Cell Lung Cancer , 2020, Lung.
[74] Muneer M. Al-Zu’bi,et al. Modelling of combination therapy using implantable anticancer drug delivery with thermal ablation in solid tumor , 2020, Scientific Reports.
[75] Jie Ma,et al. A prediction model based on DNA methylation biomarkers and radiological characteristics for identifying malignant from benign pulmonary nodules , 2020, BMC cancer.
[76] M. Sos,et al. The next tier of EGFR resistance mutations in lung cancer , 2020, Oncogene.
[77] Hua-bei Jiang,et al. MEMS Ultrasound Transducers for Endoscopic Photoacoustic Imaging Applications , 2020, Micromachines.
[78] J. Hajnal,et al. Impact of Aperture, Depth, and Acoustic Clutter on the Performance of Coherent Multi-Transducer Ultrasound Imaging , 2020, Applied sciences.
[79] N. Reguart,et al. Neoadjuvant treatment of stage IIIA-N2 in EGFR-Mutant/ALK-rearranged non-small cell lung cancer , 2020, Translational lung cancer research.
[80] Luis Abelardo Villarruel Mendoza,et al. Recent Advances in Micro-Electro-Mechanical Devices for Controlled Drug Release Applications , 2020, Frontiers in Bioengineering and Biotechnology.
[81] C. Domenici,et al. Electronic Nose as a Novel Method for Diagnosing Cancer: A Systematic Review , 2020, Biosensors.
[82] Kun Zhang,et al. Non-invasive early detection of cancer four years before conventional diagnosis using a blood test , 2020, Nature Communications.
[83] Amir Hossein Alavi,et al. Piezoelectric Sensing Techniques in Structural Health Monitoring: A State-of-the-Art Review , 2020, Sensors.
[84] I. Andrade,et al. Current Point-of-Care testing in cancer and future perspectives: a systematic review , 2020, European Journal of Public Health.
[85] Sofia Arshavsky-Graham,et al. Lab-on-a-Chip Devices for Point-of-Care Medical Diagnostics. , 2020, Advances in biochemical engineering/biotechnology.
[86] M. Lenardo,et al. A guide to cancer immunotherapy: from T cell basic science to clinical practice , 2020, Nature Reviews Immunology.
[87] G. Tortora,et al. Oncogene-Addicted Non-Small-Cell Lung Cancer: Treatment Opportunities and Future Perspectives , 2020, Cancers.
[88] Matthew A. Clarke,et al. Executable cancer models: successes and challenges , 2020, Nature Reviews Cancer.
[89] K. Choi,et al. A lung cancer-on-chip platform with integrated biosensors for physiological monitoring and toxicity assessment , 2020 .
[90] G. E. Carpagnano,et al. Fractional Exhaled Nitric Oxide (FENO) in the management of asthma: a position paper of the Italian Respiratory Society (SIP/IRS) and Italian Society of Allergy, Asthma and Clinical Immunology (SIAAIC) , 2020, Multidisciplinary respiratory medicine.
[91] Duc Han Tran,et al. Evaluation of a Liquid Biopsy Protocol using Ultra-Deep Massive Parallel Sequencing for Detecting and Quantifying Circulation Tumor DNA in Colorectal Cancer Patients , 2020, Cancer investigation.
[92] P. Hegde,et al. Top 10 Challenges in Cancer Immunotherapy. , 2020, Immunity.
[93] P. Pham,et al. Ultra-deep massively parallel sequencing with unique molecular identifier tagging achieves comparable performance to droplet digital PCR for detection and quantification of circulating tumor DNA from lung cancer patients , 2019, PloS one.
[94] A. Drilon,et al. Entrectinib in ROS1 fusion-positive non-small-cell lung cancer: integrated analysis of three phase 1-2 trials. , 2019, The Lancet. Oncology.
[95] Xueji Zhang,et al. Graphene-Based Biosensors for Detection of Biomarkers , 2019, Micromachines.
[96] A. Shaw,et al. Lorlatinib in advanced ROS1-positive non-small-cell lung cancer: a multicentre, open-label, single-arm, phase 1-2 trial. , 2019, The Lancet. Oncology.
[97] Ying Cheng,et al. Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC. , 2019, The New England journal of medicine.
[98] Guo-Hua Feng,et al. Piezoelectric Micromachined Ultrasonic Transducers with a Cost-Effective Bottom-Up Fabrication Scheme for Millimeter-Scale Range Finding , 2019, Sensors.
[99] Dongqing Wang,et al. MicroRNA-128-b regulates epidermal growth factor receptor expression in non-small cell lung cancer , 2019, Molecular medicine reports.
[100] R. Raišutis,et al. Application of sonoporation to increase anticancer drug efficacy in 2D and 3D NSCLC cell cultures , 2019, Annals of Oncology.
[101] K. Syrigos,et al. Nivolumab plus Ipilimumab in Advanced Non-Small-Cell Lung Cancer. , 2019, The New England journal of medicine.
[102] F. Forsberg,et al. Sonoporation for Augmenting Chemotherapy of Pancreatic Ductal Adenocarcinoma. , 2019, Methods in molecular biology.
[103] Huanming Yang,et al. Circulating tumor DNA detection is correlated to histologic types in patients with early-stage non-small-cell lung cancer. , 2019, Lung cancer.
[104] P. Navin Karanth,et al. Recent trends in mechanical micropumps and their applications: A review , 2019, Mechatronics.
[105] I. Ong,et al. Development and characterization of patient-derived xenografts from non-small cell lung cancer brain metastases , 2020, Scientific Reports.
[106] Vinay Singh,et al. Cancer Nanotechnology: A New Revolution for Cancer Diagnosis and Therapy. , 2019, Current drug metabolism.
[107] J. Bamber,et al. Plane wave versus focused transmissions for contrast enhanced ultrasound imaging: the role of parameter settings and the effects of flow rate on contrast measurements , 2019, Physics in medicine and biology.
[108] S. C. Wang,et al. Crizotinib in ROS1-rearranged advanced non-small-cell lung cancer (NSCLC): updated results, including overall survival, from PROFILE 1001 , 2019, Annals of oncology : official journal of the European Society for Medical Oncology.
[109] W. Liang,et al. Non-invasive diagnosis of early-stage lung cancer using high-throughput targeted DNA methylation sequencing of circulating tumor DNA (ctDNA) , 2019, Theranostics.
[110] Jian-yong Ding,et al. Strategies to overcome acquired resistance to EGFR TKI in the treatment of non-small cell lung cancer , 2019, Clinical and Translational Oncology.
[111] Takashi Takiguchi,et al. Ultrasonic Tomographic Technique and Its Applications , 2019, Applied Sciences.
[112] Hardik J Pandya,et al. Electronic nose: a non-invasive technology for breath analysis of diabetes and lung cancer patients , 2019, Journal of breath research.
[113] Joseph V. Hajnal,et al. Coherent Multi-Transducer Ultrasound Imaging , 2019, IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control.
[114] M. Prausnitz,et al. Rapidly separable microneedle patch for the sustained release of a contraceptive , 2019, Nature Biomedical Engineering.
[115] Hojong Choi,et al. Prelinearized Class-B Power Amplifier for Piezoelectric Transducers and Portable Ultrasound Systems , 2019, Sensors.
[116] Ali Khademhosseini,et al. Biodegradable Gelatin Methacryloyl Microneedles for Transdermal Drug Delivery , 2018, Advanced healthcare materials.
[117] David R. Jones,et al. Perioperative mortality and morbidity after sublobar versus lobar resection for early-stage non-small-cell lung cancer: post-hoc analysis of an international, randomised, phase 3 trial (CALGB/Alliance 140503). , 2018, The Lancet. Respiratory medicine.
[118] Rafiq Ahmad,et al. Deposition of nanomaterials: A crucial step in biosensor fabrication , 2018, Materials Today Communications.
[119] Madara Tirzïte,et al. Detection of lung cancer with electronic nose and logistic regression analysis , 2018, Journal of breath research.
[120] S. Patnaik,et al. An Immuno-Biochip Selectively Captures Tumor-Derived Exosomes and Detects Exosomal RNAs for Cancer Diagnosis. , 2018, ACS applied materials & interfaces.
[121] A. Fekry,et al. A novel simple biosensor containing silver nanoparticles/propolis (bee glue) for microRNA let-7a determination. , 2018, Materials science & engineering. C, Materials for biological applications.
[122] R. Yadava,et al. MEMS sensor array-based electronic nose for breath analysis—a simulation study , 2018, Journal of breath research.
[123] Nivaldo T. Schiefler,et al. Generation and Analysis of Ultrasound Images Using Plane Wave and Sparse Arrays Techniques , 2018, Sensors.
[124] P. Ascierto,et al. Second-line Treatment of Advanced Non-small Cell Lung Cancer Non-oncogene Addicted: New Treatment Algorithm in the Era of Novel Immunotherapy. , 2018, Current clinical pharmacology.
[125] E. Diamandis,et al. Utility of circulating tumor DNA in cancer diagnostics with emphasis on early detection , 2018, BMC Medicine.
[126] D. Planchard,et al. Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC , 2018, The New England journal of medicine.
[127] L. Altucci,et al. Sonoporation by microbubbles as gene therapy approach against liver cancer , 2018, Oncotarget.
[128] E. Braunwald,et al. Time to Add a Fifth Pillar to Bedside Physical Examination: Inspection, Palpation, Percussion, Auscultation, and Insonation , 2018, JAMA cardiology.
[129] K. Kabashima,et al. Anti-PD-1 and Anti-CTLA-4 Therapies in Cancer: Mechanisms of Action, Efficacy, and Limitations , 2018, Front. Oncol..
[130] Gordana Vunjak-Novakovic,et al. Organs-on-a-Chip: A Fast Track for Engineered Human Tissues in Drug Development. , 2018, Cell stem cell.
[131] Funda Meric-Bernstam,et al. Efficacy of Larotrectinib in TRK Fusion–Positive Cancers in Adults and Children , 2018, The New England journal of medicine.
[132] C. Kelsey,et al. Surgery versus stereotactic body radiation therapy for stage I non–small cell lung cancer: A comprehensive review , 2018, Cancer.
[133] Xinghua Gao,et al. Nanofiber membrane supported lung-on-a-chip microdevice for anti-cancer drug testing. , 2018, Lab on a chip.
[134] Roy S. Herbst,et al. The biology and management of non-small cell lung cancer , 2018, Nature.
[135] Chuanbin Wu,et al. Intradermal delivery of STAT3 siRNA to treat melanoma via dissolving microneedles , 2018, Scientific Reports.
[136] Arash Rafii,et al. Halfway between 2D and Animal Models: Are 3D Cultures the Ideal Tool to Study Cancer-Microenvironment Interactions? , 2018, International journal of molecular sciences.
[137] John Quackenbush,et al. Cancer subtype identification using somatic mutation data , 2017, British Journal of Cancer.
[138] Witold Rzyman,et al. European position statement on lung cancer screening. , 2017, The Lancet. Oncology.
[139] Mu Chiao,et al. Microfabricated Drug Delivery Devices: Design, Fabrication, and Applications , 2017 .
[140] Libin Guo,et al. The Roles of microRNAs in Regulating the Expression of PD-1/PD-L1 Immune Checkpoint , 2017, International journal of molecular sciences.
[141] H. Wakelee,et al. Adjuvant chemotherapy with or without bevacizumab in patients with resected non-small-cell lung cancer (E1505): an open-label, multicentre, randomised, phase 3 trial , 2017, The Lancet. Oncology.
[142] Donald E Ingber,et al. Human Organ Chip Models Recapitulate Orthotopic Lung Cancer Growth, Therapeutic Responses, and Tumor Dormancy In Vitro. , 2017, Cell reports.
[143] Hossam Haick,et al. Detection of Lung Cancer and EGFR Mutation by Electronic Nose System , 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[144] T. Okinaga,et al. Epidermal growth factor receptor-targeted sonoporation with microbubbles enhances therapeutic efficacy in a squamous cell carcinoma model , 2017, PloS one.
[145] Tarek Mekhail,et al. Durvalumab after Chemoradiotherapy in Stage III Non–Small‐Cell Lung Cancer , 2017, The New England journal of medicine.
[146] Caroline Dive,et al. Progress and prospects of early detection in lung cancer , 2017, Open Biology.
[147] Joe Y. Chang,et al. 7‐year follow‐up after stereotactic ablative radiotherapy for patients with stage I non–small cell lung cancer: Results of a phase 2 clinical trial , 2017, Cancer.
[148] E. Scalzetti,et al. Biopsy first: Lessons learned from Cancer and Leukemia Group B (CALGB) 140503 , 2017, The Journal of thoracic and cardiovascular surgery.
[149] Sharina Kort,et al. Data analysis of electronic nose technology in lung cancer: generating prediction models by means of Aethena , 2017, Journal of breath research.
[150] M. Ahn,et al. Open-Label, Multicenter, Phase II Study of Ceritinib in Patients With Non-Small-Cell Lung Cancer Harboring ROS1 Rearrangement. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[151] Pradnya Palekar Shanbhag,et al. BioMicroelectromechanical systems: A novel approach for drug targeting in chronic diseases , 2017 .
[152] J. McPherson,et al. Molecular heterogeneity of non‐small cell lung carcinoma patient‐derived xenografts closely reflect their primary tumors , 2017, International journal of cancer.
[153] Peixuan Guo,et al. Inhibition of cancer migration and invasion by knocking down delta-5-desaturase in COX-2 overexpressed cancer cells , 2017, Redox biology.
[154] Walter J Curran,et al. Lung cancer: current therapies and new targeted treatments , 2017, The Lancet.
[155] M. Zehetbauer,et al. A review of the most important failure, reliability and nonlinearity aspects in the development of microelectromechanical systems (MEMS) , 2017 .
[156] Y. Shentu,et al. Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer. , 2016, The New England journal of medicine.
[157] V. Svetovoy,et al. A micropump driven by electrochemically produced short-lived bubbles , 2016 .
[158] J. Voorneveld,et al. Viability of endothelial cells after ultrasound-mediated sonoporation: Influence of targeting, oscillation, and displacement of microbubbles. , 2016, Journal of controlled release : official journal of the Controlled Release Society.
[159] Xiancheng Li,et al. Design and Construction of a Multi-Organ Microfluidic Chip Mimicking the in vivo Microenvironment of Lung Cancer Metastasis. , 2016, ACS applied materials & interfaces.
[160] R. Doebele,et al. Neoadjuvant Oncogene-Targeted Therapy in Early Stage Non-Small-Cell Lung Cancer as a Strategy to Improve Clinical Outcome and Identify Early Mechanisms of Resistance. , 2016, Clinical lung cancer.
[161] C. Amos,et al. Clinical Genotyping of Non–Small Cell Lung Cancers Using Targeted Next-Generation Sequencing: Utility of Identifying Rare and Co-mutations in Oncogenic Driver Genes1 , 2016, Neoplasia.
[162] Héctor Vázquez-Leal,et al. Recent Advances of MEMS Resonators for Lorentz Force Based Magnetic Field Sensors: Design, Applications and Challenges , 2016, Sensors.
[163] Ilia V. Uvarov,et al. A simple electrochemical micropump: Design and fabrication , 2016 .
[164] A. Shaw,et al. Resisting Resistance: Targeted Therapies in Lung Cancer. , 2016, Trends in cancer.
[165] Jie He,et al. Epidemiology of Lung Cancer. , 2016, Surgical oncology clinics of North America.
[166] Pedro Estrela,et al. Introduction to biosensors , 2016, Essays in biochemistry.
[167] Sudhir Chandra,et al. An innovative gas sensor incorporating ZnO–CuO nanoflakes in planar MEMS technology , 2016 .
[168] J. McConville,et al. The function and performance of aqueous aerosol devices for inhalation therapy , 2016, The Journal of pharmacy and pharmacology.
[169] Kenneth E. Rosenzweig,et al. Scientific Advances in Lung Cancer 2015 , 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[170] K. Unterkofler,et al. A Compendium of Volatile Organic Compounds (VOCs) Released By Human Cell Lines , 2016, Current medicinal chemistry.
[171] Peter C. Searson,et al. In Vitro Tumor Models: Advantages, Disadvantages, Variables, and Selecting the Right Platform , 2016, Front. Bioeng. Biotechnol..
[172] E. Buchbinder,et al. CTLA-4 and PD-1 Pathways , 2016, American journal of clinical oncology.
[173] Yong Peng,et al. The role of MicroRNAs in human cancer , 2016, Signal Transduction and Targeted Therapy.
[174] K. B. Sutradhar,et al. Implantable microchip: the futuristic controlled drug delivery system , 2016, Drug delivery.
[175] P. Jänne,et al. ALCHEMIST Trials: A Golden Opportunity to Transform Outcomes in Early-Stage Non–Small Cell Lung Cancer , 2015, Clinical Cancer Research.
[176] R. Onimaru,et al. Prospective Trial of Stereotactic Body Radiation Therapy for Both Operable and Inoperable T1N0M0 Non-Small Cell Lung Cancer: Japan Clinical Oncology Group Study JCOG0403. , 2015, International journal of radiation oncology, biology, physics.
[177] Chun-Ming Tsai,et al. Adjuvant Erlotinib Versus Placebo in Patients With Stage IB-IIIA Non-Small-Cell Lung Cancer (RADIANT): A Randomized, Double-Blind, Phase III Trial. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[178] E. Tagliabue,et al. Aerosol Delivery in the Treatment of Lung Cancer. , 2015, Current cancer drug targets.
[179] R. McCormack,et al. EGFR mutation incidence in non-small-cell lung cancer of adenocarcinoma histology: a systematic review and global map by ethnicity (mutMapII). , 2015, American journal of cancer research.
[180] L. Crinò,et al. Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer. , 2015, The New England journal of medicine.
[181] P. Economopoulou,et al. Beyond EGFR and ALK inhibition: unravelling and exploiting novel genetic alterations in advanced non small-cell lung cancer. , 2015, Cancer treatment reviews.
[182] D. Planchard,et al. A randomized phase II study of the MEK1/MEK2 inhibitor trametinib (GSK1120212) compared with docetaxel in KRAS-mutant advanced non-small-cell lung cancer (NSCLC)†. , 2015, Annals of oncology : official journal of the European Society for Medical Oncology.
[183] Robert Langer,et al. An implantable microdevice to perform high-throughput in vivo drug sensitivity testing in tumors , 2015, Science Translational Medicine.
[184] Xiliang Luo,et al. Scaling up an electrochemical signal with a catalytic hairpin assembly coupling nanocatalyst label for DNA detection. , 2015, Chemical communications.
[185] Yongqiang Qiu,et al. Piezoelectric Micromachined Ultrasound Transducer (PMUT) Arrays for Integrated Sensing, Actuation and Imaging , 2015, Sensors.
[186] H. Seol,et al. Patient-Derived Xenografts from Non–Small Cell Lung Cancer Brain Metastases Are Valuable Translational Platforms for the Development of Personalized Targeted Therapy , 2014, Clinical Cancer Research.
[187] D. Ingber,et al. Microfluidic organs-on-chips , 2014, Nature Biotechnology.
[188] Yen-Liang Liu,et al. Differentiation of lung stem/progenitor cells into alveolar pneumocytes and induction of angiogenesis within a 3D gelatin--microbubble scaffold. , 2014, Biomaterials.
[189] Saurabh Srivastava,et al. Nanomaterial-Based Biosensors for Food Toxin Detection , 2014, Applied Biochemistry and Biotechnology.
[190] Myoung-Hee Kim,et al. The health impacts of semiconductor production: an epidemiologic review , 2014, International journal of occupational and environmental health.
[191] Krzysztof Schabowicz,et al. Ultrasonic tomography – The latest nondestructive technique for testing concrete members – Description, test methodology, application example , 2014 .
[192] Mickael Tanter,et al. Ultrafast imaging in biomedical ultrasound , 2014, IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control.
[193] Takao Sugiyama,et al. Sonoporation: Gene transfer using ultrasound. , 2013, World journal of methodology.
[194] Marcel Bruins,et al. Enabling a transferable calibration model for metal-oxide type electronic noses , 2013 .
[195] J. Jett,et al. Gefitinib versus placebo in completely resected non-small-cell lung cancer: results of the NCIC CTG BR19 study. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[196] G. Cloutier,et al. Stolt's f-k migration for plane wave ultrasound imaging , 2013, IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control.
[197] G. Giaccone,et al. Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology. , 2013, The Journal of molecular diagnostics : JMD.
[198] J. Wolchok,et al. At the Bedside: CTLA‐4‐ and PD‐1‐blocking antibodies in cancer immunotherapy , 2013, Journal of leukocyte biology.
[199] M. Ladanyi,et al. ALK Rearrangements Are Mutually Exclusive with Mutations in EGFR or KRAS: An Analysis of 1,683 Patients with Non–Small Cell Lung Cancer , 2013, Clinical Cancer Research.
[200] R. Schreiber,et al. Cancer immunoediting: antigens, mechanisms, and implications to cancer immunotherapy , 2013, Annals of the New York Academy of Sciences.
[201] Bastien Denarie,et al. Coherent Plane Wave Compounding for Very High Frame Rate Ultrasonography of Rapidly Moving Targets , 2013, IEEE Transactions on Medical Imaging.
[202] P. Jänne,et al. New targetable oncogenes in non-small-cell lung cancer. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[203] Tristan D Yan,et al. Video-assisted thoracic surgery versus open thoracotomy for non-small cell lung cancer: a meta-analysis of propensity score-matched patients. , 2013, Interactive cardiovascular and thoracic surgery.
[204] Klaus Müllen,et al. Three-dimensional graphene-based macro- and mesoporous frameworks for high-performance electrochemical capacitive energy storage. , 2012, Journal of the American Chemical Society.
[205] E. Meng,et al. MEMS-enabled implantable drug infusion pumps for laboratory animal research, preclinical, and clinical applications. , 2012, Advanced drug delivery reviews.
[206] F. V. van Schooten,et al. The versatile use of exhaled volatile organic compounds in human health and disease , 2012, Journal of breath research.
[207] G. Giaccone,et al. Tyrosine kinase inhibitors in lung cancer. , 2012, Hematology/oncology clinics of North America.
[208] Jill Maben,et al. Implementing patient-centred cancer care: using experience-based co-design to improve patient experience in breast and lung cancer services , 2012, Supportive Care in Cancer.
[209] M. Grinstaff,et al. Local drug delivery strategies for cancer treatment: gels, nanoparticles, polymeric films, rods, and wafers. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[210] U. Pastorino,et al. Patient-Derived Xenografts of Non Small Cell Lung Cancer: Resurgence of an Old Model for Investigation of Modern Concepts of Tailored Therapy and Cancer Stem Cells , 2012, Journal of biomedicine & biotechnology.
[211] Tao Chen,et al. Metamaterials Application in Sensing , 2012, Sensors.
[212] M. Zorzetto,et al. Targeting EGFR in non-small-cell lung cancer: lessons, experiences, strategies. , 2012, Respiratory medicine.
[213] A. Dirksen,et al. CT screening for lung cancer brings forward early disease. The randomised Danish Lung Cancer Screening Trial: status after five annual screening rounds with low-dose CT , 2012, Thorax.
[214] J. Hickman,et al. Design Optimization of Liquid-Phase Flow Patterns for Microfabricated Lung on a Chip , 2012, Annals of Biomedical Engineering.
[215] Christine Jérôme,et al. In vivo biocompatibility of three potential intraperitoneal implants. , 2011, Macromolecular bioscience.
[216] Dzelaludin Junuzovic,et al. Application of Ultrasound in Medicine , 2011, Acta informatica medica : AIM : journal of the Society for Medical Informatics of Bosnia & Herzegovina : casopis Drustva za medicinsku informatiku BiH.
[217] John Fox,et al. Cancer Multidisciplinary Team Meetings: Evidence, Challenges, and the Role of Clinical Decision Support Technology , 2011, International journal of breast cancer.
[218] Nitin Afzulpurkar,et al. Micro Electromechanical Systems (MEMS) Based Microfluidic Devices for Biomedical Applications , 2011, International journal of molecular sciences.
[219] Ke Liu,et al. Thermoplastic microfluidic devices and their applications in protein and DNA analysis. , 2011, The Analyst.
[220] J. Weber. Immune checkpoint proteins: a new therapeutic paradigm for cancer--preclinical background: CTLA-4 and PD-1 blockade. , 2010, Seminars in oncology.
[221] J. Padilla,et al. Preoperative chemotherapy plus surgery versus surgery plus adjuvant chemotherapy versus surgery alone in early-stage non-small-cell lung cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[222] D. Ingber,et al. Reconstituting Organ-Level Lung Functions on a Chip , 2010, Science.
[223] Hui Li,et al. Ultrasensitive electrochemical detection for DNA arrays based on silver nanoparticle aggregates. , 2010, Analytical chemistry.
[224] D. Yates,et al. Breath Analysis of Lung Cancer Patients Using an Electronic Nose Detection System , 2010, IEEE Sensors Journal.
[225] Menachem Nathan,et al. Microbattery technologies for miniaturized implantable medical devices. , 2010, Current pharmaceutical biotechnology.
[226] John Gohring,et al. Detection of HER2 breast cancer biomarker using the opto-fluidic ring resonator biosensor , 2010 .
[227] J. Pignon,et al. Adjuvant Cisplatin and Vinorelbine for Completely Resected Non-small Cell Lung Cancer: Subgroup Analysis of the Lung Adjuvant Cisplatin Evaluation , 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[228] N. Altorki,et al. Thoracoscopic lobectomy is associated with lower morbidity than open lobectomy: a propensity-matched analysis from the STS database. , 2010, The Journal of thoracic and cardiovascular surgery.
[229] M. Berry,et al. Risk factors for morbidity after lobectomy for lung cancer in elderly patients. , 2009, The Annals of thoracic surgery.
[230] S. Digumarthy,et al. Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[231] I. Horváth,et al. Exhaled biomarkers in lung cancer , 2009, European Respiratory Journal.
[232] M. Fink,et al. Coherent plane-wave compounding for very high frame rate ultrasonography and transient elastography , 2009, IEEE Transactions on Ultrasonics, Ferroelectrics and Frequency Control.
[233] David Erickson,et al. A robust, electrochemically driven microwell drug delivery system for controlled vasopressin release , 2009, Biomedical microdevices.
[234] D. Ma,et al. Paclitaxel-octreotide conjugates in tumor growth inhibition of A549 human non-small cell lung cancer xenografted into nude mice. , 2008, European journal of pharmacology.
[235] David J Sugarbaker,et al. Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[236] Richard J Stephens,et al. Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[237] A. Ullrich,et al. Paul Ehrlich's magic bullet concept: 100 years of progress , 2008, Nature Reviews Cancer.
[238] Derek Y. Chiang,et al. Characterizing the cancer genome in lung adenocarcinoma , 2007, Nature.
[239] E. Birney,et al. Patterns of somatic mutation in human cancer genomes , 2007, Nature.
[240] D. Haber,et al. Cancer: Drivers and passengers , 2007, Nature.
[241] Zulfiqur Ali,et al. Data analysis for electronic nose systems , 2006 .
[242] K. Mundt. Cancer risk in the semiconductor industry: responding to the call for action , 2006, Occupational and Environmental Medicine.
[243] M. Fischbach,et al. “Oncogenic Shock”: Explaining Oncogene Addiction through Differential Signal Attenuation , 2006, Clinical Cancer Research.
[244] Shuming Nie,et al. Multicolor quantum dots for molecular diagnostics of cancer , 2006, Expert review of molecular diagnostics.
[245] J. Minna,et al. Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers. , 2006, Journal of the National Cancer Institute.
[246] A. Gazdar,et al. Somatic mutations of epidermal growth factor receptor signaling pathway in lung cancers , 2006, International journal of cancer.
[247] A. Barzegar,et al. Piezoelectric micromachined ultrasonic transducers based on PZT thin films , 2005, IEEE Transactions on Ultrasonics, Ferroelectrics and Frequency Control.
[248] T. Velten,et al. Packaging of bio-MEMS: strategies, technologies, and applications , 2005, IEEE Transactions on Advanced Packaging.
[249] B. Laube,et al. The expanding role of aerosols in systemic drug delivery, gene therapy, and vaccination. , 2005, Respiratory care.
[250] A. Bardelli,et al. Genetic analysis of the kinome and phosphatome in cancer , 2005, Cellular and Molecular Life Sciences CMLS.
[251] Robert Livingston,et al. Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer. , 2005, The New England journal of medicine.
[252] P. Mazzone,et al. Detection of lung cancer by sensor array analyses of exhaled breath. , 2005, American journal of respiratory and critical care medicine.
[253] H. Varmus,et al. KRAS Mutations and Primary Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib , 2005, PLoS medicine.
[254] Jennifer A Hollingsworth,et al. Pushing the band gap envelope: mid-infrared emitting colloidal PbSe quantum dots. , 2004, Journal of the American Chemical Society.
[255] R. Schreiber,et al. The immunobiology of cancer immunosurveillance and immunoediting. , 2004, Immunity.
[256] K. Kinzler,et al. Cancer genes and the pathways they control , 2004, Nature Medicine.
[257] R. Schreiber,et al. The three Es of cancer immunoediting. , 2004, Annual review of immunology.
[258] Wolfgang Knoll,et al. Alloyed Zn(x)Cd(1-x)S nanocrystals with highly narrow luminescence spectral width. , 2003, Journal of the American Chemical Society.
[259] L. Seymour,et al. Clinical predictive value of the in vitro cell line, human xenograft, and mouse allograft preclinical cancer models. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[260] C. Densmore. The re-emergence of aerosol gene delivery: a viable approach to lung cancer therapy. , 2003, Current Cancer Drug Targets.
[261] P. Anderson,et al. Aerosol therapy for malignancy involving the lungs. , 2003, Current cancer drug targets.
[262] Kevin Gleeson,et al. Detection of lung cancer with volatile markers in the breath. , 2003, Chest.
[263] Y. Miller,et al. Chromosomal abnormalities in non-small cell lung carcinomas and in bronchial epithelia of high-risk smokers detected by multi-target interphase fluorescence in situ hybridization. , 2003, The Journal of molecular diagnostics : JMD.
[264] R. Bianco,et al. Epidermal growth factor receptor (HER1) tyrosine kinase inhibitor ZD1839 (Iressa) inhibits HER2/neu (erbB2)-overexpressing breast cancer cells in vitro and in vivo. , 2001, Cancer research.
[265] Ravi Kumar M.N.V.. Nano and microparticles as controlled drug delivery devices. , 2000 .
[266] E Harper,et al. Enhanced efficacy of a novel controlled release paclitaxel formulation (PACLIMER delivery system) for local-regional therapy of lung cancer tumor nodules in mice. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[267] G. S. Wilson,et al. Electrochemical Biosensors: Recommended Definitions and Classification , 1999, Biosensors & bioelectronics.
[268] E. Shimizu,et al. Tumor suppressor genes in human lung cancer. , 1997, The journal of medical investigation : JMI.
[269] M. Loda,et al. Polymerase chain reaction-based methods for the detection of mutations in oncogenes and tumor suppressor genes. , 1994, Human pathology.
[270] Julian W. Gardner,et al. A brief history of electronic noses , 1994 .
[271] C. Laurencin,et al. Polymeric controlled release systems: new methods for drug delivery. , 1987, Clinics in laboratory medicine.
[272] L. Mazutis,et al. Microfluidics for Cancer Biomarker Discovery, Research, and Clinical Application. , 2022, Advances in experimental medicine and biology.
[273] A. Jemal,et al. Cancer statistics, 2018 , 2018, CA: a cancer journal for clinicians.
[274] L. Paz-Ares,et al. Mechanisms of acquired resistance to first- and second-generation EGFR tyrosine kinase inhibitors , 2018, Annals of oncology : official journal of the European Society for Medical Oncology.
[275] S. Gettinger,et al. Nivolumab plus ipilimumab as first-line treatment for advanced non-small-cell lung cancer (CheckMate 012): results of an open-label, phase 1, multicohort study. , 2017, The Lancet. Oncology.
[276] H. Groen,et al. Dabrafenib plus trametinib in patients with previously treated BRAF(V600E)-mutant metastatic non-small cell lung cancer: an open-label, multicentre phase 2 trial. , 2016, The Lancet. Oncology.
[277] J. Zwischenberger,et al. Nodal Upstaging During Lung Cancer Resection Is Associated With Surgical Approach. , 2016, The Annals of thoracic surgery.
[278] S. Chandra,et al. A MEMS based acetone sensor incorporating ZnO nanowires synthesized by wet oxidation of Zn film , 2014 .
[279] M. van Griensven,et al. Sonoporation increases therapeutic efficacy of inducible and constitutive BMP2/7 in vivo gene delivery. , 2014, Human gene therapy methods.
[280] Javed Ali,et al. Exploring targeted pulmonary delivery for treatment of lung cancer , 2013, International journal of pharmaceutical investigation.
[281] Lucio Crinò,et al. Selumetinib plus docetaxel for KRAS-mutant advanced non-small-cell lung cancer: a randomised, multicentre, placebo-controlled, phase 2 study. , 2013, The Lancet. Oncology.
[282] Anita Šalić,et al. Application of microreactors in medicine and biomedicine , 2012 .
[283] Said F. Al-Sarawi,et al. Modelling and simulation of wirelessly and securely interrogated low-powered actuators for bio-MEMS , 2010 .
[284] Brian Findlay,et al. Randomized phase III trial of vinorelbine plus cisplatin compared with observation in completely resected stage IB and II non-small-cell lung cancer: updated survival analysis of JBR-10. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[285] A. Robitzki,et al. Biosensing and drug delivery at the microscale : novel devices for controlled and responsive drug delivery. , 2010, Handbook of experimental pharmacology.
[286] P. Diot,et al. Aerosolized chemotherapy. , 2008, Journal of aerosol medicine and pulmonary drug delivery.
[287] Erkki Heikkola,et al. Model-based optimization of ultrasonic transducers. , 2005, Ultrasonics sonochemistry.
[288] Paul Flecknell,et al. Replacement, reduction and refinement. , 2002, ALTEX.
[289] Yousef Saad,et al. Parallel Iterative Methods for Sparse Linear Systems , 2001 .